BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Roche Holding AG (“Roche” or the “Company”) (OTC: RHHBY) securities between March 2, 2017 through June 5, 2017, inclusive (the “Class Period”). Roche investors have until August 7, 2017 to file a lead plaintiff motion.
Investors suffering losses on their Roche investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to firstname.lastname@example.org.
On June 5, 2017, news reports stated that a new study showed that adding Roche’s breast cancer drug Perjeta to its older treatment Herceptin only had a slight benefit, while more than doubling the one-year treatment cost; and that the combination of Perjeta with Herceptin had higher rates of certain side effects than Herceptin alone, including severe diarrhea.
In addition, also on June 5, 2017, an investigation by STAT revealed that Roche’s rheumatoid arthritis drug Actemra has been associated with heart attacks, strokes and heart failure at least as often as some competing drugs despite not carrying the same warnings in its prescribing information. Following this news, Roche shares fell $1.75 per share, or over 5%, to close at $34.14 per share.
The complaint filed in this lawsuit alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose issues with Roche’s breast cancer drugs Perjeta and Herceptin.
If you purchased shares of Roche during the Class Period you may move the Court no later than August 7, 2017 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.